Non-small cell lung cancer (nsclc) Clinical Trials
Conditions / Non-small cell lung cancer (nsclc)
Delta Trials records 3 clinical trials for Non-small cell lung cancer (nsclc) in its publicly accessible dataset. From the full dataset, 2 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 57 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
3
Total Trials
2
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
57
Study Locations
Browse by location (57 total)
- Los Angeles, United States 2 trialsAll trials in Los Angeles, United States
- Boston, United States 2 trialsAll trials in Boston, United States
- Rochester, United States 2 trialsAll trials in Rochester, United States
- Houston, United States 2 trialsAll trials in Houston, United States
- Ulm, Germany 1 trialAll trials in Ulm, Germany
- Columbus, United States 1 trialAll trials in Columbus, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- Shanghai, China 1 trialAll trials in Shanghai, China
- Xi’an, China 1 trialAll trials in Xi’an, China
- Zhengzhou, China 1 trialAll trials in Zhengzhou, China
- Phoenix, United States 1 trialAll trials in Phoenix, United States
- Candiolo, Italy 1 trialAll trials in Candiolo, Italy
- Nantong, China 1 trialAll trials in Nantong, China
- Celebration, United States 1 trialAll trials in Celebration, United States
- Bologna, Italy 1 trialAll trials in Bologna, Italy
- Lyon, France 1 trialAll trials in Lyon, France
- Jacksonville, United States 1 trialAll trials in Jacksonville, United States
- Beijing, China 1 trialAll trials in Beijing, China
- Jinan, China 1 trialAll trials in Jinan, China
- Washington D.c., United States 1 trialAll trials in Washington D.c., United States